The report contains information, which mutations of specific genes are present in a patient and which conclusions could be drawn for the efficacy of a therapy with targeted drugs. Thereby a potentially efficient targeted therapy should be found for patients and inefficient therapies should be avoided. This serves to support physicians during therapy planning.
To some extent drugs are suggested as therapy option which are not yet approved and are still in clinical trials. There is the possibility that patients take part in these clinical studies if corresponding conditions are fulfilled.
In addition the report contains information about the ctDNA level.